Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
 wosene.asefa@nih.gov
240-276-6422 		5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
 kajal.biswas2@nih.gov
240-276-5614 		5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
 brian.cholewa@nih.gov
240-276-7545 		5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
 john.clifford@nih.gov
202-235-4482 		5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
 vignesh.gunasekharan@nih.gov
240-276-5814 		5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
 altaf.mohammed@nih.gov
240-276-6082 		5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
 ancy.nalli@nih.gov
202-276-5265 		5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
 shizuko.sei@nih.gov
240-276-5005 		5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
 robert.shoemaker@nih.gov
240-276-7077 		5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
 anda.vlad@nih.gov
240-276-6422 		5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name PI Organization Title Grant Number Program Official
Huang, Ying

Fred Hutchinson Cancer Center
United States

 Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-03 Matthew Young, Ph.D.
Huang, Ying

Western University Of Health Sciences
United States

 Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-04 Anda Vlad, M.D., Ph.D.
Huang, Yijian

Emory University
United States

 Analytic diagnosis methods for disease ruling 5R01CA283687-02 Guillermo Marquez, Ph.D.
Huberty, Jennifer Lynne

University Of Texas Hlth Science Center
United States

 Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients 5R01CA262041-05 Marjorie Perloff, M.D.
Huh, Warner King

University Of Alabama At Birmingham
United States

 Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) 3R01CA279021-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hui, David

University Of Tx Md Anderson Can Ctr
United States

 Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology 5R01CA288515-02 Brennan Streck, Ph.D., RN, M.P.H.
Hundley, William Gregory

Wake Forest University Health Sciences
United States

 Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-05 Eileen Dimond, R.N., M.S.
Hur, Chin

Columbia University Health Sciences
United States

 Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 3R01CA257333-05S1 Matthew Young, Ph.D.
Hutson, Alan David

Roswell Park Cancer Institute Corp
United States

 Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center 1U24CA305623-01 Altaf Mohammed, Ph.D.
Huttenhower, Curtis

Broad Institute, Inc.
United States

 PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297578-01S1 Asad Umar, D.V.M., Ph.D.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

 Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-04 Matthew Young, Ph.D.
Im, Eun-Ok

University Of Texas At Austin
United States

 Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors 5R33CA280979-04 Brennan Streck, Ph.D., RN, M.P.H.
Infante, Rodney E

Ut Southwestern Medical Center
United States

 Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 3R01CA266900-04S1 Marjorie Perloff, M.D.
Irvin, William J

Southeast Clinical Oncol Res Consortium
United States

 NCI Community Oncology Research Program 2025 Extension Request 3UG1CA189858-11S1 Vanessa A. White, M.P.H.
Iwelunmor, Juliet

Washington University
United States

 Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) 3U01CA279863-04S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.